This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Series B round for Phase Bioscience raises $25mm; closed at $48.4mm
13 Aug 2012
Phase Bioscience (developing cost-effective production technology to purify protein and peptide therapeutics, improving their efficacy and side-effect profiles) has closed its Series B venture round. Johnson & Johnson Development Corp. Hatteras Venture Partners, and Fletcher Spaght Ventures brought in the initial $4mm. The company will use the proceeds to continue developing purification and drug delivery technologies acquired from Duke University. In connection with the financing, a member of J&J Development Corp. will take a seat on Phase Bioscience's board.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?